Abstract:Controlled ovarian stimulation is tailored to the patient based on clinical parameters but estimating the number of retrieved metaphase II (MII) oocytes is a challenge. Here, we have developed a model that takes advantage of the patient's genetic and clinical characteristics simultaneously for predicting the stimulation outcome. Sequence variants in reproduction-related genes identified by next-generation sequencing were matched to groups of various MII oocyte counts using ranking, correspondence analysis, and self-organizing map methods. The gradient boosting machine technique was used to train models on a clinical dataset of 8,574 or a clinical-genetic dataset of 516 ovarian stimulations. The clinical-genetic model predicted the number of MII oocytes better than that based on clinical data. Anti-Müllerian hormone level and antral follicle count were the two most important predictors while a genetic feature consisting of sequence variants in the GDF9 , LHCGR , FSHB , ESR1 , and ESR2 genes was the third. The combined contribution of genetic features important for the prediction was over one-third of that revealed for anti-Müllerian hormone. Predictions of our clinical-genetic model accurately matched individuals' actual outcomes preventing over- or underestimation. The genetic data upgrades the personalized prediction of ovarian stimulation outcomes, thus improving the in vitro fertilization procedure. Infertility is a condition that leads to the failure of natural conception. It affects more than 186 million people worldwide. Because in vitro fertilization (IVF) is an effective infertility treatment, optimizing the steps in the process is essential to best assist those trying to conceive. The IVF process begins with ovarian stimulation during which the woman takes ovary-stimulating hormones, i.e., gonadotropins, to produce a certain number of viable, fertilization-ready egg cells, but predicting the number of egg cells collected after such stimulation is difficult. These predictions are usually based on the patient's clinical parameters and depend on the physician's experience, making them highly subjective. Here, we used machine learning to identify features that physicians could adopt to predict the number of egg cells obtained after ovarian stimulation. We found that clinical parameters (anti-Müllerian hormone level and antral follicle count), as well as genetic characteristics (variants in reproduction-related genes— GDF9 , LHCGR , FSHB , ESR1 , and ESR2 ), are important features that increase the accuracy of such predictions. Our predictive model has been designed to help physicians tailor the protocols used for ovarian stimulation on a case-by-case basis, thereby improving the safety and efficiency of the IVF process.

Preovulatory progesterone levels are the top indicator for ovulation prediction based on machine learning model evaluation: a retrospective study

A Clinician-Friendly Machine Learning System to Predict Ovarian Response and Deploy Individualized Ovarian Stimulation Strategies in IVF

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Improved clinical pregnancy rates in natural frozen-thawed embryo transfer cycles with machine learning ovulation prediction: insights from a retrospective cohort study

Prospective observational cohort study: Computational models for early prediction of ongoing pregnancy in fresh IVF/ICSI-ET protocols

The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation

Multifactor Prediction of Embryo Transfer Outcomes Based on a Machine Learning Algorithm

Machine learning for predicting elective fertility preservation outcomes

Decrease in Preovulatory Serum Estradiol is a Valuable Marker for Predicting Premature Ovulation in Natural/unstimulated in Vitro Fertilization Cycle

Machine Learning-Based Modeling of Ovarian Response and the Quantitative Evaluation of Comprehensive Impact Features

Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology

Evaluation of oocyte maturity using artificial intelligence quantification of follicle volume biomarker by three-dimensional ultrasound

Predicting ovarian responses to the controlled ovarian hyperstimulation in elderly infertile women using clinical measurements and random forest regression

Personalized prediction of live birth prior to the first in vitro fertilization treatment: a machine learning method

Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data

Prediction of clinical pregnancy outcome after single fresh blastocyst transfer during in vitro fertilization: an ensemble learning perspective

Predictive models for live birth outcomes of FET: Improving clinical decision-making based on machine learning analysis

12355 Prediction of in-Vitro Fertilization Outcome by Ultrasound Strain Analysis and Machine Learning: A Multi-Centre Study